Invitrogen™ Human LGI2 Synthetic Peptide

Ref.: BL-RE-176367Manufacturer ref.: PEP-0613 50 μg
€149.00 excl. VAT

LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.

Gene ID (Enter)
55203
Species
Human
Purification method
Purified
Accession number
Q8N0V4
Common name
Human LGI2
Brand
Invitrogen

LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.

LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.

The leucine-rich, glioma inactivated gene 2 (LGI2) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI2 have not been found to be associated with ADTLE.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15358770
Specifications
Gene ID (Enter)55203
SpeciesHuman
Purification methodPurified
Accession numberQ8N0V4
Common nameHuman LGI2
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)LGI2
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0613
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.